Mechanisms and therapeutic potential of chinonin in nervous system diseases

• Published in: Journal of asian natural products research Vol. 26; no. 12; pp. 1405 - 1420
• Main Authors: Hui, Zhang, Lai-Fa, Wang, Xue-Qin, Wang, Ling, Deng, Bin-Sheng, He, Li, Jian-Ming
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 01.12.2024; Taylor & Francis Ltd
• Subjects: Anemarrhena; Anemarrhena - chemistry; Animals; Anti-Inflammatory Agents - chemistry; Anti-Inflammatory Agents - pharmacology; Anti-Inflammatory Agents - therapeutic use; antioxidants; Antioxidants - chemistry; Antioxidants - pharmacology; brain damage; Brain injury; Flavonoids; Head injuries; Humans; immunity; mitochondria; Molecular Structure; Nervous system; Nervous system diseases; Nervous System Diseases - drug therapy; Neurological diseases; Neuroprotection; Neuroprotective Agents - chemistry; Neuroprotective Agents - pharmacology; Neuroprotective Agents - therapeutic use; Pharmacology; protective effect; rhizomes; therapeutics; Xanthones - chemistry; Xanthones - pharmacology

The flavonoid compound chinonin is one of the main active components of Rhizoma anemarrhena with multiple activities, including anti-inflammatory and antioxidant properties, protection of mitochondrial function and regulation of immunity. In this paper, we reviewed recent research progress on the pr...